Integris Hospice

Oklahoma City – November 10, 2026 -- Hospice agencies can deliver blood and platelet transfusions at home to patients with blood cancers at a cost of $571 per patient per week, according to a University of Oklahoma pilot study of 20 people. The researchers hope the data will support a federal reimbursement model for the service.

Pilot Study Reports No Hospitalizations or Transfusion Reactions

Published in eClinicalMedicine, a journal in The Lancet family, the study covered patients who had stopped pursuing treatment aimed at controlling their cancer. Hospice-administered transfusions kept hemoglobin and platelet levels within a range consistent with clinical transfusion guidelines. No patients were admitted to the hospital or intensive care unit, and no transfusion reactions were reported.